Skip to main content

Table 3 Analysis of abnormal miRNAexpression in the training set (\(\bar x \pm \;{\rm{s}}\))

From: Clinical value of peripheral blood miR-21 and miR-486 combined with CT forearly cancer diagnosis in pulmonary nodulessmoking

Gene

Control group (n = 30)

Benign lung nodule group (n = 34)

Malignant pulmonary nodule group (n = 31)

Variance ratio

P value

miR-375

1.72 ± 0.34

1.64 ± 0.31

1.71 ± 0.30

5.227

0.144

miR-126

7.49 ± 1.03

6.37 ± 0.58

6.42 ± 0.54

3.449

0.295

miR-21

0.65 ± 0.18

4.28 ± 0.85

5.66 ± 0.72

14.056

0.007

miR-210

1.05 ± 0.25

1.81 ± 0.34

1.15 ± 0.54

4.672

0.142

miR-486

7.94 ± 0.77

5.42 ± 0.55

4.14 ± 0.32

12.005

0.013